drugset / Trial / NCT01199328

Study to Evaluate the Interaction Between Aspirin and Nexium

NCT01199328

Phase 1 Completed 34 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess the interaction between aspirin and Nexium in healthy volunteers.

Timeline

Start
2010-09
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg Oral
Comparator Esomeprazole Small molecule 20 mg Oral

Indications

No indication recorded.